Addressing Gaps for Women With HIV Involved in the Criminal Justice System

Jaimie P. Meyer, MD, from the Yale School of Medicine, discusses her work on identifying opportunities to reduce risk for HIV transmission, particularly in women ...

Treating and Preventing HIV With Generic Drugs

Generic antiretroviral agents have had a dramatic effect on outcomes in developing nations, and their availability in developed countries is rapidly expanding as more brand-name ...

Treating Major Depressive Disorder Improves Outcomes in HIV

Mental health problems are 1 of the most important reasons for failing to engage in long-term control of HIV.

Improving Adherence to ART in HIV

The rapidly developing landscape of antiretroviral therapy adherence monitoring has great potential for clinical application, but cost-effectiveness and feasibility studies are needed to define the ...

Preventing HIV, STIs Through School-Based Programs

Although a positive impact on behavior change has been reported following the implementation of curriculum-based programs, there is a lack of clear evidence that school-based ...

PrEP Crucial for People Involved in Criminal Justice Systems

Important strategies to consider for people involved in the criminal justice systems include linkage to antiretroviral therapy for those who are HIV positive and linkage ...

Pausing ART: Safety and Ethical Considerations

Dr Gianella Weibel talks with Dr Li and Dr Dubé, investigators of a new study from the AIDS Clinical Trials Group, which uses an intensively ...
HIV/AIDS

Latest News

Provider Opioid Prescribing Practices for PLWHIV

Provider Opioid Prescribing Practices for PLWHIV

HIV providers' belief on whether chronic opioid therapy helps keep PLWHIV engaged with care may be associated with differences in these practices.

Better Physician-Patient Relationship Reduces Hospital Readmissions for PLWHIV

Better Physician-Patient Relationship Reduces Hospital Readmissions for PLWHIV

Several studies have determined that PLWHIV have a higher risk for 30-day readmission than the general population.

Early ART in HIV Possible Key to Dolutegravir Monotherapy Success

Early ART in HIV Possible Key to Dolutegravir Monotherapy Success

Dolutegravir monotherapy was noninferior to combination antiretroviral therapy (cART) in patients who started cART during primary HIV infection.

High Risk for Virologic Failure With Dolutegravir Monotherapy in Chronic HIV

High Risk for Virologic Failure With Dolutegravir Monotherapy in Chronic HIV

Because of high risk for virologic failure and of the emergence of INSTI resistance, dolutegravir monotherapy should be avoided as a maintenance strategy.

Thymidine Analogues, Didanosine Associated With Cardiovascular Risk

Thymidine Analogues, Didanosine Associated With Cardiovascular Risk

There may be a potentially irreversible and harmful association of thymidine analogues and didanosine with visceral adipose tissue accumulation in PLWHIV.

Two-Step Gender Identity Question Aids in Risk Stratification

Two-Step Gender Identity Question Aids in Risk Stratification

A 2-step gender identity question led to a 4.8-fold increase in ascertainment of transgender patients at a clinic for STDs.

CDC: Most Black HIV Patients Interviewed for Partner Services

CDC: Most Black HIV Patients Interviewed for Partner Services

78 percent of partners identified were notified of potential exposure; 47 percent were tested for HIV

Conditional Financial Incentives Increase Linkage to Care for Male Partners of Antenatal Clinic Attendees

Conditional Financial Incentives Increase Linkage to Care for Male Partners of Antenatal Clinic Attendees

HIV self-test kits combined with financial incentives may encourage men to attend the clinic for post-test HIV services.

Cardiovascular Disease Events and Statin Eligibility in Patients With HIV

Cardiovascular Disease Events and Statin Eligibility in Patients With HIV

More patients with HIV who were not recommended for statin therapy experienced cardiovascular disease events compared with a control group.

DPP-4 Inhibition May Reduce Atherogenesis in HIV

DPP-4 Inhibition May Reduce Atherogenesis in HIV

Treatment with sitagliptin had no effect on soluble CD14 when given to participants with virally suppressed HIV infection.

Feature Article

HIV Control Criteria: Overview & Expert Roundtable

HIV Control Criteria: Overview & Expert Roundtable

Although the overall number of new HIV infections has declined worldwide, it is estimated that 5000 new infections occur each day.

HIV & Cancer Risk: Expert Interview

HIV & Cancer Risk: Expert Interview

Although rates of AIDS-defining malignancies have declined in recent decades, cancer remains a leading cause of mortality in people living with HIV.

Insight Into the HIV Self-Testing Debate

Insight Into the HIV Self-Testing Debate

Although the CDC recommends routine HIV screening for all people age 13-64 years, numerous barriers to HIV testing in healthcare settings have been identified, including lack of access and fear of stigma and discrimination.

Telling Children Their HIV Status: Interview With Dr Elizabeth Lowenthal

Telling Children Their HIV Status: Interview With Dr Elizabeth Lowenthal

Infectious Disease Advisor speaks with Elizabeth D. Lowenthal, MD, about the challenges associated with revealing HIV seropositive status to children.

Psychosocial Interventions in HIV: How Best to Support HIV-Positive Patients

Psychosocial Interventions in HIV: How Best to Support HIV-Positive Patients

Mental health professionals supporting patients living with HIV need to make space for their patients to process the emotional effect of their diagnosis, but not to make assumptions about what it means to them.

Vagus Nerve Stimulation May Improve HIV-Associated Depression

Vagus Nerve Stimulation May Improve HIV-Associated Depression

Transcutaneous vagus nerve stimulation could provide a safe alternative treatment in HIV-depression by targeting both depression and other comorbidities that can burden people living with HIV.

How HIV Affects Cervical Cancer Risk and Outcomes

How HIV Affects Cervical Cancer Risk and Outcomes

Women with HIV have an increased risk for persistent HPV infection, which frequently progresses to cervical cancer, and they should be warned of their increased risk for HPV and cervical cancer and, when appropriate, advised to undergo HPV vaccination.

Linkage to HIV Care: To Give or Not to Give Financial Incentives?

Linkage to HIV Care: To Give or Not to Give Financial Incentives?

Use of incentives makes the most sense with disadvantaged populations including homeless, drug users, and people in developing countries.

Role of the Microbiome on HIV Infection, Prevention, and Treatment

Role of the Microbiome on HIV Infection, Prevention, and Treatment

The interactions between HIV, ART, human sexual behavior, and the gut microbiome are complex and sorting out these interactions will be important to design future interventions.

Adolescents at Risk for HIV Should Be Offered PrEP

Adolescents at Risk for HIV Should Be Offered PrEP

Experts discuss new findings supporting the need for PrEP in adolescents and discuss the continued debate surrounding parental consent and other relevant issues.

Slideshows

SIGN UP FOR FREE E-NEWSLETTERS